Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids
| Trial ID | NCT06297278 |
| Status | Recruiting |
| Condition | Adolescence |
| Intervention | Moderate Intensity Exercise |
Adolescent anxiety disorders represent a critical therapeutic gap, with conventional treatments showing limited efficacy in developing brains. This trial addresses a fundamental need by investigating whether acute exercise can enhance fear extinction through endocannabinoid modulation—potentially offering a novel, accessible intervention for youth anxiety.
This ongoing recruitment-phase trial examines whether moderate-intensity exercise can improve fear extinction learning in adolescents through enhanced frontolimbic brain activity and endocannabinoid signaling. The study focuses on adolescent participants and measures both neurobiological markers and behavioral outcomes related to fear regulation. Investigators are testing the hypothesis that exercise-induced endocannabinoid release can optimize the neural circuits responsible for extinguishing pathological fear responses.
“If positive, this trial could establish exercise as a precision medicine tool for adolescent anxiety treatment, leveraging the endocannabinoid system’s natural capacity for fear regulation. This represents exactly the kind of mechanism-based intervention we need—using endogenous cannabinoid pathways rather than exogenous compounds in developing brains.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is this adolescent exercise and fear extinction trial studying?
The trial (NCT06297278) is examining whether moderate-intensity exercise can improve fear extinction learning in adolescents. Researchers are looking at whether this happens through enhanced frontolimbic brain activity and endocannabinoid signaling, and they are measuring both neurobiological markers and behavioral outcomes related to fear regulation.
Is this exercise trial for teens still enrolling participants?
Yes. The trial is listed with a status of recruiting and is described as being in its recruitment phase. It focuses on adolescent participants and tests moderate-intensity exercise as the intervention. Because it is ongoing, it is not yet known whether exercise improves fear extinction in this group.
How might exercise affect the endocannabinoid system and fear?
Investigators are testing the hypothesis that exercise-induced release of endocannabinoids can optimize the neural circuits responsible for extinguishing pathological fear responses. This is a hypothesis under study, not an established finding, and the trial is designed to test whether it holds in adolescents.
Why does this trial focus on anxiety in adolescents?
Adolescent anxiety disorders are described as a critical therapeutic gap, with conventional treatments showing limited efficacy in developing brains. The trial investigates whether acute exercise can enhance fear extinction through endocannabinoid modulation, which could potentially offer a novel, accessible intervention for youth anxiety.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
